Repaglinide
Repaglinide is a benzoic acid-derived insulin secretagogue used to treat type 2 diabetes. It is a valuable research tool for studying pancreatic beta-cell function and glucose metabolism in both in vitro and in vivo experimental models. Rare cases of drug-induced liver injury have been associated with its clinical use.
Product Specifications
CAS Number
135062-02-1
Product Name Alternative
Secretagogue, PotassiumChannel, Potassium Channel, PPARγ, Repaglinide, type-2, inhibit, mellitus., Inhibitor, insulin, diabetes, CMBA, benzoic, carbamoylmethyl, acid, AG-EE 388 ZW, AG-EE 623ZW
Field of Research
Neuroscience
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
[C@H] (NC (CC1=CC (OCC) =C (C (O) =O) C=C1) =O) (CC (C) C) C2=C (C=CC=C2) N3CCCCC3
Molecular Formula
C27H36N2O4
Molecular Weight
452.6
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-Ethoxy-4-[2-[[ (1S) -3-methyl-1- (2-piperidin-1-ylphenyl) butyl]amino]-2-oxoethyl]benzoic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
